Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2013 Oct 1.

Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2012 Aug 16;21(10):1792–1798. doi: 10.1158/1055-9965.EPI-12-0674

TABLE 3.

Joint BRAF / MSI status and survival after colorectal cancer diagnosis

	Disease-Specific Survival		Overall Survival

	Deaths / Cases	HR (95% CI)^a	Deaths / Cases	HR (95% CI)^a
BRAF-wildtype / MSS	375/1494	1.00 (ref)	581/1494	1.00 (ref)
BRAF-wildtype / MSI-H	22/171	0.60 (0.39–0.93)	49/171	0.84 (0.62–1.12)
BRAF-mutated / MSS	38/109	1.60 (1.14–2.23)	49/109	1.24 (0.92–1.66)
BRAF-mutated / MSI-H	14/126	0.57 (0.33–0.98)	51/126	0.99 (0.73–1.33)

^a

Adjusted for age at diagnosis, sex, time from diagnosis to enrollment, and stage.